Kamel Izeradjene

5.0k total citations
16 papers, 1.5k citations indexed

About

Kamel Izeradjene is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Kamel Izeradjene has authored 16 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Kamel Izeradjene's work include Cell death mechanisms and regulation (7 papers), NF-κB Signaling Pathways (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Kamel Izeradjene is often cited by papers focused on Cell death mechanisms and regulation (7 papers), NF-κB Signaling Pathways (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Kamel Izeradjene collaborates with scholars based in United States, France and Italy. Kamel Izeradjene's co-authors include Jean‐Pierre Revillard, Leslie Douglas, Janet A. Houghton, Sunil R. Hingorani, Laurent Genestier, Laurence Quéméneur, Romain Paillot, Markus A. Carlson, David M. Tillman and Ralph H. Hruban and has published in prestigious journals such as Cell, Cancer Cell and Cancer Research.

In The Last Decade

Kamel Izeradjene

15 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kamel Izeradjene United States 13 724 714 341 223 153 16 1.5k
Yasushi Saga Japan 22 670 0.9× 354 0.5× 200 0.6× 251 1.1× 104 0.7× 66 1.4k
Jennifer DeVecchio United States 18 910 1.3× 599 0.8× 248 0.7× 287 1.3× 102 0.7× 34 1.5k
Emily Chu United States 7 1.3k 1.8× 627 0.9× 319 0.9× 191 0.9× 71 0.5× 14 1.7k
Jean S. Beebe United States 19 636 0.9× 314 0.4× 415 1.2× 142 0.6× 72 0.5× 39 1.7k
Shweta Joshi United States 23 655 0.9× 382 0.5× 403 1.2× 239 1.1× 74 0.5× 48 1.5k
Orlando Musso France 23 812 1.1× 427 0.6× 138 0.4× 478 2.1× 165 1.1× 40 1.6k
Rita Humeniuk United States 14 818 1.1× 647 0.9× 178 0.5× 541 2.4× 108 0.7× 31 1.8k
Jeena Joseph India 17 722 1.0× 864 1.2× 285 0.8× 373 1.7× 155 1.0× 41 1.8k
Shoichiro Tsuji Japan 13 672 0.9× 726 1.0× 418 1.2× 249 1.1× 145 0.9× 20 1.4k
Anniina Färkkilä Finland 21 929 1.3× 648 0.9× 153 0.4× 265 1.2× 124 0.8× 51 1.7k

Countries citing papers authored by Kamel Izeradjene

Since Specialization
Citations

This map shows the geographic impact of Kamel Izeradjene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamel Izeradjene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamel Izeradjene more than expected).

Fields of papers citing papers by Kamel Izeradjene

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamel Izeradjene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamel Izeradjene. The network helps show where Kamel Izeradjene may publish in the future.

Co-authorship network of co-authors of Kamel Izeradjene

This figure shows the co-authorship network connecting the top 25 collaborators of Kamel Izeradjene. A scholar is included among the top collaborators of Kamel Izeradjene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamel Izeradjene. Kamel Izeradjene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
DiGiammarino, Enrico L., Kamel Izeradjene, Fiona Harding, et al.. (2020). Beyond Binding Kinetics: Stoichiometry via SPR can identify novel binding modes, assess ligand quality and inform functional design in biopharmaceutical discovery.. The FASEB Journal. 34(S1). 1–1.
2.
Whittle, Martin C., Kamel Izeradjene, Priya Rani, et al.. (2015). RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma. Cell. 161(6). 1345–1360. 156 indexed citations
3.
Stromnes, Ingunn M., J. Scott Brockenbrough, Kamel Izeradjene, et al.. (2014). Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity. Gut. 63(11). 1769–1781. 255 indexed citations
4.
Izeradjene, Kamel, Chelsea Combs, Aarthi Gopinathan, et al.. (2007). KrasG12D and Smad4/Dpc4 Haploinsufficiency Cooperate to Induce Mucinous Cystic Neoplasms and Invasive Adenocarcinoma of the Pancreas. Cancer Cell. 11(3). 229–243. 271 indexed citations
5.
Izeradjene, Kamel & Sunil R. Hingorani. (2007). Targets, Trials, and Travails in Pancreas Cancer. Journal of the National Comprehensive Cancer Network. 5(10). 1042–1053. 9 indexed citations
6.
Izeradjene, Kamel, Leslie Douglas, Massimo Dominici, et al.. (2006). Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of smac/DIABLO from the mitochondria. Pathology & Oncology Research. 12(3). 133–142. 31 indexed citations
7.
8.
9.
Izeradjene, Kamel, et al.. (2004). Influence of Casein Kinase II in Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Human Rhabdomyosarcoma Cells. Clinical Cancer Research. 10(19). 6650–6660. 50 indexed citations
10.
11.
Peták, István, Kamel Izeradjene, Leslie Douglas, et al.. (2003). A caspase-8-independent component in TRAIL/Apo-2L-induced cell death in human rhabdomyosarcoma cells. Cell Death and Differentiation. 10(6). 729–739. 28 indexed citations
12.
Tillman, David M., et al.. (2003). Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C.. PubMed. 63(16). 5118–25. 90 indexed citations
13.
Izeradjene, Kamel, et al.. (2001). Inhibition of thymidine synthesis by folate analogues induces a Fas–Fas ligand-independent deletion of superantigen-reactive peripheral T cells. International Immunology. 13(1). 85–93. 15 indexed citations
14.
Izeradjene, Kamel & Jean‐Pierre Revillard. (2001). APOPTOSIS OF SUPERANTIGEN-ACTIVATED T CELLS INDUCED BY MYCOPHENOLATE MOFETIL TREATMENT1. Transplantation. 71(1). 118–124. 33 indexed citations
15.
Izeradjene, Kamel, Laurence Quéméneur, Marie‐Cécile Michallet, Nathalie Bonnefoy, & J. P. Révillard. (2001). Mycophenolate mofetil interferes with interferon γ production in T-cell activation models. Transplantation Proceedings. 33(3). 2110–2111. 10 indexed citations
16.
Genestier, Laurent, Romain Paillot, Laurence Quéméneur, Kamel Izeradjene, & Jean‐Pierre Revillard. (2000). Mechanisms of action of methotrexate. Immunopharmacology. 47(2-3). 247–257. 329 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasushi Saga Breakdown of academic impact, for papers by Jennifer DeVecchio Breakdown of academic impact, for papers by Emily Chu Breakdown of academic impact, for papers by Jean S. Beebe Breakdown of academic impact, for papers by Shweta Joshi Breakdown of academic impact, for papers by Orlando Musso Breakdown of academic impact, for papers by Rita Humeniuk Breakdown of academic impact, for papers by Jeena Joseph Breakdown of academic impact, for papers by Shoichiro Tsuji Breakdown of academic impact, for papers by Anniina Färkkilä
Rankless by CCL
2026